Orion Biotechnology Presenting at the 3rd GPCR-Targeted Drug Discovery Summit in Boston
06. März 2024 20:30 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, March 06, 2024 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
18. Juli 2023 11:33 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston
16. Februar 2023 13:15 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Publishes Whitepaper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs
02. Februar 2023 10:07 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate
01. Dezember 2022 11:08 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference
10. November 2022 09:03 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Ontario, Canada, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously...
Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference
11. Oktober 2022 09:03 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target
12. Juli 2022 11:22 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada & Pittsburgh, USA, July 12, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs),...
ORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARD
05. Juli 2022 10:03 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 05, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company targeting previously-undruggable G Protein-Coupled Receptors (GPCRs), today...
ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE
10. Mai 2022 13:03 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs),...